Partelli, S, Massironi, S, Zerbi, A, Niccoli, P, Kwon, W, Landoni, L, Panzuto, F, Tomazic, A, Bongiovanni, A, Kaltsas, G, Sauvanet, A, Bertani, E, Mazzaferro, V, Caplin, M, Armstrong, T, Weickert, MO, Ramage, J, Segelov, E, Butturini, G, Staettner, S, Cives, M, Frilling, A, Moulton, CA, He, J, Boesch, F, Selberheer, A, Twito, O, Castaldi, A, De Angelis, CG, Gaujoux, S, Holzer, K, Wilson, CH, Almeamar, H, Vigia, E, Muffatti, F, Lucà, M, Lania, A, Ewald, J, Kim, H, Salvia, R, Rinzivillo, M, Smid, A, Gardini, A, Tsoli, M, Hentic, O, Colombo, S, Citterio, D, Toumpanakis, C, Ramsey, E, Randeva, HS, Srirajaskanthan, R
, Croagh, D, Regi, P, Gasteiger, S, Invernizzi, P, Ridolfi, C, Giovannini, M, Jang, JY, Bassi, C & Falconi, M 2022, '
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial',
British Journal of Surgery, vol. 109, no. 12, pp. 1186-1190.
https://doi.org/10.1093/bjs/znac267